A1 Exterminators

Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company based in Cambridge, MA. They are a trusted leader in the renal community, dedicated to delivering unique products to people with kidney disease. Akebia's team works tirelessly to address complications of kidney disease and is committed to advancing new hope for those affected by this serious and life-altering illness. With a focus on research and development, Akebia is at the forefront of innovation in the field of kidney disease. They have developed a commercially available medicine and a late-stage oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) called vadadustat, which is based on Nobel Prize-winning science. While vadadustat is approved for use in 34 countries, it has not yet received approval from the U.S. Food and Drug Administration.Generated from the website

Shape Biopharmaceuticals Inc., based in Cambridge, MA, is an innovative developer of next-generation immunotherapies aimed at addressing chronic human diseases with significant unmet treatment needs. The company leverages advanced computational epitope-specific antigen design and cutting-edge nanoparticle engineering technologies to create a new class of immunotherapeutic drugs. Focusing on optimizing immunotherapy design and delivery, Shape Biopharmaceuticals employs leading-edge computational drug design and protein engineering to enhance the immunological properties of target antigens. Their pioneering approach includes the development of structurally defined engineered nanomedicines that utilize the immune system to generate personalized therapeutic antibodies directly in patients. Generated from the website

ViaCord, based in Cambridge, MA, is a leading cord blood banking company that offers comprehensive services for storing and utilizing cord blood and cord tissue stem cells. With a focus on providing peace of mind to parents, ViaCord offers affordable pricing options and a convenient enrollment process. Their state-of-the-art processing and storage facilities ensure the preservation of stem cells for potential future use in treating nearly 80 diseases, as well as ongoing research in regenerative medicine. ViaCord is committed to providing the highest quality services and remains at the forefront of advancements in cord blood banking. As part of their commitment to customer satisfaction, ViaCord offers a sibling connection program, allowing families to potentially use stored cord blood for siblings in need. Additionally, ViaCord provides genomic testing services, although these are not intended for diagnostic purposes. With a strong emphasis on privacy and security, ViaCord adheres to strict privacy policies and terms and conditions. As a trusted and reputable cord blood banking company, ViaCord continues to make significant contributions to the field of stem cell research and treatment.Generated from the website